4-(2-benzothiazol-2-ylthio)aniline
|
- $149 - $608
- Product name: 4-(2-benzothiazol-2-ylthio)aniline
- CAS: 25712-17-8
- MF: C13H10N2S2
- MW: 258.36
- EINECS:247-204-8
- MDL Number:MFCD00629030
- Synonyms:4-(2-benzothiazol-2-ylthio)aniline;4-(2-Benzothiazolylthio)benzenamine;Benzenamine, 4-(2-benzothiazolylthio)-;4-(Benzo[d]thiazol-2-ylthio)aniline
4 prices
Selected condition:
Brand
- aablocks
- Chemenu
- Crysdot
- Oakwood
Package
- 100mg
- 1g
- Manufactureraablocks
- Product numberAA00C24T
- Product description4-(Benzothiazol-2-ylsulfanyl)phenylamine
- Packaging100mg
- Price$173
- Updated2026-05-28
- Buy
- ManufacturerChemenu
- Product numberCM312417
- Product description4-(Benzo[d]Thiazol-2-ylthio)aniline 95%
- Packaging1g
- Price$608
- Updated2026-05-26
- Buy
- ManufacturerCrysdot
- Product numberCD11157808
- Product description4-(Benzo[d]Thiazol-2-ylthio)aniline 95+%
- Packaging1g
- Price$412
- Updated2026-05-26
- Buy
- ManufacturerOakwood
- Product number015530
- Product description4-(Benzothiazol-2-ylsulfanyl)phenylamine
- Packaging100mg
- Price$149
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA00C24T | 4-(Benzothiazol-2-ylsulfanyl)phenylamine | 100mg | $173 | 2026-05-28 | Buy |
| Chemenu | CM312417 | 4-(Benzo[d]Thiazol-2-ylthio)aniline 95% | 1g | $608 | 2026-05-26 | Buy |
| Crysdot | CD11157808 | 4-(Benzo[d]Thiazol-2-ylthio)aniline 95+% | 1g | $412 | 2026-05-26 | Buy |
| Oakwood | 015530 | 4-(Benzothiazol-2-ylsulfanyl)phenylamine | 100mg | $149 | 2021-12-16 | Buy |
Properties
Melting point :121-123°
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|




